SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000919574-18-002772
Filing Date
2018-03-30
Accepted
2018-03-30 16:35:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7856080_13da.htm SC 13D/A 103287
  Complete submission text file 0000919574-18-002772.txt   104949
Mailing Address BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS, L.P. (Filed by) CIK: 0001278386 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Subject) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89221 | Film No.: 18726437
SIC: 2835 In Vitro & In Vivo Diagnostic Substances